Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-22T05:45:12.340Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of Hydroxocobalamin on Surface Oximetry in Nonexposed Humans

Published online by Cambridge University Press:  01 May 2013

Brian V. Cashin Jr. ,
Aaron G. Matlock ,
Chris Kang ,
Penny S. Reynolds  and
Brandon K. Wills
Brian V. Cashin Jr.
Affiliation:
Department of Emergency Medicine, Madigan Army Medical Center, Tacoma, Washington USA
Aaron G. Matlock
Affiliation:
Department of Emergency Medicine, Madigan Army Medical Center, Tacoma, Washington USA
Chris Kang
Affiliation:
Department of Emergency Medicine, Madigan Army Medical Center, Tacoma, Washington USA
Penny S. Reynolds
Affiliation:
Department of Emergency Medicine, VCU Medical Center, Richmond, Virginia USA
Brandon K. Wills*
Affiliation:
Department of Emergency Medicine, VCU Medical Center, Richmond, Virginia USA Virginia Poison Center, Richmond, Virginia USA
*
Correspondence: Brandon Wills, DO, MS Associate Professor, VCU Medical Center 600 East Broad St. Richmond, VA 23219 USA E-mail bwills@mcvh-vcu.edu
Get access Rights & Permissions [Opens in a new window]

Abstract

Introduction

The newer cyanide antidote, hydroxocobalamin, due to its pigmentation, has been found to cause interferences in some laboratory assays. Co-oximetry may also be affected by hydroxocobalamin, leading to false elevations in hemoglobin concentration, methemoglobin, carboxyhemoglobin, and false decreases in oxyhemoglobin. The Masimo Radical-7 is a medical device that performs noninvasive oximetry and estimates hemoglobin (Hb) concentration and percent carboxyhemoglobin (COHb), methemoglobin (MetHb), and oxyhemoglobin saturation (O2Hb).

Study Objectives

The study sought to determine the effect of hydroxocobalamin on noninvasive measurement of hemoglobin indices using the Masimo Radical-7 monitor.

Methods

Seven asymptomatic volunteers who were unexposed to cyanide had baseline heart rate (HR), blood pressure (BP), and oximeter measurements recorded followed by an infusion of five grams of hydroxocobalamin over 15 minutes. The above parameters were subsequently recorded at: 5, 10, 15, 30 and 60 minutes post infusion. Data were analyzed by calculating the area under the curve (AUC) for each variable and comparing the results to expected values by paired t tests. Expected AUC values were calculated by extrapolating baseline values across the entire time period.

Results

The mean differences from baseline values with 95% confidence intervals and t tests of mean difference were: SBP: 11 mm Hg (95% CI, 0-22; P = .051); HR: -9 (95% CI, -15 to -3; P = .01); Hb: -0.1 (95% CI, -0.7 to 0.4; P = .57); O2Hb: 0 g/dL (95% CI, -1 to 1; P = .41); COHb: -1 (95% CI, -3 to 1; P = .25); MetHb: -0.2 (95% CI, -0.3 to 0; P = .03).

Discussion

After infusion of hydroxocobalamin there was a significant elevation of systolic blood pressure and decrease in heart rate. There were no significant differences in Hb, O2Hb, and COHb. Although percent methemoglobin concentrations were statistically lower, the authors feel this difference is of trivial clinical significance.

Conclusion

The administration of hydroxocobalamin does not significantly impact noninvasive oximetry.

CashinB, MatlockA, KangC, ReynoldsP, WillsB. Effect of Hydroxocobalamin on Surface Oximetry in Nonexposed Humans. Prehosp Disaster Med. 2013;28(4):1-3.

Keywords

co-oximetrycyanidehydroxocobalamin
Type
Original Research
Information
Prehospital and Disaster Medicine , Volume 28 , Issue 4 , August 2013 , pp. 367 - 369
Copyright
Copyright © World Association for Disaster and Emergency Medicine 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Dart, RC. Hydroxocobalamin for acute cyanide poisoning: new data from preclinical and clinical studies; new results from the prehospital emergency setting. Clin Toxicol (Phila). 2006;44(Suppl 1):1-3.Google ScholarPubMed
2.Fortin, JL, Giocanti, JP, Ruttimann, M, et al. Prehospital administration of hydroxocobalamin for smoke inhalation-associated cyanide poisoning: 8 years of experience in the Paris Fire Brigade. Clin Toxicol (Phila). 2006;44(Suppl 1):37-44.CrossRefGoogle ScholarPubMed
3.Borron, SW, Baud, FJ, Barriot, P, et al. Prospective study of hydroxocobalamin for acute cyanide poisoning in smoke inhalation. Ann Emerg Med. 2007;49(6):794-801, 801 e791-792.CrossRefGoogle ScholarPubMed
4. Cyanokit [package insert]. Napa, California: Dey, L.P.; 2007.Google Scholar
5.Beaudeux, JL, Flourie, F, Peynet, J, et al. Hydroxocobalamin and sodium thiosulfate interfere negatively with measurement of creatine kinase activity. Clin Chem. 1994;40(11 Pt 1):2120-2121.CrossRefGoogle ScholarPubMed
6.Curry, SC, Connor, DA, Raschke, RA. Effect of the cyanide antidote hydroxocobalamin on commonly ordered serum chemistry studies. Ann Emerg Med. 1994;24(1):65-67.CrossRefGoogle ScholarPubMed
7.Vest, P, Renaudeau, C, Tellal, S, et al. Interference of hydroxocobalamin treatment on commun biochemical determinations [in French]. Ann Biol Clin (Paris). 2002;60(1):57-64.Google ScholarPubMed
8.Denninghoff, K, Walter, FG, Langa, AJ, et al. Spectrophotometry of hydroxocobalamin and hemoglobin reveals production of an unanticipated methemoglobin variant. Clin Toxicol (Phila). 2008;46(6):545-550.CrossRefGoogle ScholarPubMed
9.Lee, J, Mukai, D, Kreuter, K, et al. Potential interference by hydroxocobalamin on cooximetry hemoglobin measurements during cyanide and smoke inhalation treatments. Ann Emerg Med. 2007;49(6):802-805.CrossRefGoogle ScholarPubMed